Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia

Wenbing Liu, Yu Liu, Anli Lai, Runxia Gu, Ying Wang, Qing Rao, Yingchang Mi, Hui Wei, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2927.

https://doi.org/10.1182/blood-2024-198599

Published: 2024

Journal Articles

Integrative Multi-Omics Analyses Identify a High-Risk Subgroup of Patients with Poor Prognosis in t(8;21) Acute Myeloid Leukemia

Yu Liu, Wenbing Liu, Yihan Mei, Qing Rao, Runxia Gu, Min Wang, Jianxiang Wang, Shaowei Qiu

Blood (2024) 144 (Supplement 1): 328.

https://doi.org/10.1182/blood-2024-194287

Published: 2024

Journal Articles

ADGRG1/GPR56 As a Marker of CD8 + Tumor-Reactive T Cells in Acute Myeloid Leukemia

Yihan Mei, Yu Liu, Wenbing Liu, Manling Chen, Qing Rao, Min Wang, Shaowei Qiu, Runxia Gu, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 4289.

https://doi.org/10.1182/blood-2024-194281

Published: 2024

Journal Articles

Mapping T-ALL to T Cell Differentiation Trajectory Identifies an ETP-like Subgroup Arrested at an Early Stage of T Cell Development

Heye Yu, Wenbing Liu, Junping Zhang, Leling Xie, Anli Lai, Zheng Tian, Kejing Tang, Haiyan Xing, Wang Ying, Hui Wei, Qing Rao, Runxia Gu, Min Wang, Huijun Wang, Jianxiang Wang, Shaowei Qiu

Blood (2024) 144 (Supplement 1): 1463.

https://doi.org/10.1182/blood-2024-194208

Published: 2024

Journal Articles

CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

Chengcai Guo, Yu Liu, Qing Rao, Runxia Gu, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2024) 144 (Supplement 1): 2734.

https://doi.org/10.1182/blood-2024-194291

Published: 2024

Journal Articles

The Immune Editing Process Reshapes the AML1-ETO Fusion Protein-Induced Pre-Leukemia Microenvironment

Yihan Mei, Manling Chen, Runxia Gu, Shaowei Qiu, Qing Rao, Min Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 5710.

https://doi.org/10.1182/blood-2023-178305

Published: 2023

Journal Articles

IKZF2 Specifically Participates in AML1-ETO Mediated Blockage of Myeloid Differentiation

Yu Liu, Chengcai Guo, Wenbing Liu, Xiaoyu Liu, Qing Rao, Runxia Gu, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 2750.

https://doi.org/10.1182/blood-2023-179854

Published: 2023

Journal Articles

Pre-Leukemic Transformation of the Bone Marrow Microenvironment Induced By AML1-ETO Fusion Protein

Manling Chen, Yihan Mei, Xiaoyu Liu, Qing Rao, Runxia Gu, Shaowei Qiu, Min Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 5613.

https://doi.org/10.1182/blood-2023-179881

Published: 2023

Journal Articles

CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

Chengcai Guo, Yu Liu, Qing Rao, Shaowei Qiu, Runxia Gu, Min Wang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 5697.

https://doi.org/10.1182/blood-2023-179262

Published: 2023

Journal Articles

AML1-ETO and CCND2 Overexpression Cooperate to Drive AML Initiation and Progression

Junli Mou, Yu Liu, Xiaoyu Liu, Runxia Gu, Yingxi Xu, Kejing Tang, Zheng Tian, Haiyan Xing, Qing Rao, Min Wang, Shaowei Qiu, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 4129.

https://doi.org/10.1182/blood-2023-179869

Published: 2023

Journal Articles

Structural Optimization of Dual-Target CD22/CD19 CAR-T and Its Anti-Tumor Effects on B Cell Malignancies

Yu Zhang, Ying Wang, Runxia Gu, Lin Shi, Yongzeng Wang, Yi Feng, Lulu Lv, Qing Rao, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 630–631.

https://doi.org/10.1182/blood-2022-162345

Published: 2022

Journal Articles

Construction of Dual- and Enhanced Dual-Antibodies Targeting CD19 in the Treatment of B-ALL and Investigation of the Relevant Mechanisms

Manling Chen, Shaowei Qiu, Xiaoyu Liu, Ting Zhang, Huizhen He, Runxia Gu, Yingxi Xu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 3271–3272.

https://doi.org/10.1182/blood-2022-158785

Published: 2022

Journal Articles

The Characteristics of AML1-ETO Fusion Gene Induced Pre-Leukemia Immune Microenvironment

Yihan Mei, Manling Chen, Xiaoyu Liu, Runxia Gu, Shaowei Qiu, Qing Rao, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 3019–3020.

https://doi.org/10.1182/blood-2022-158724

Published: 2022

Journal Articles

Investigation of Impact Induced By AML1-ETO on Self-Renewal and Differentiation of Hematopoietic Stem and Progenitor Cells in Pre-Leukemic Stage

Xiaoyu Liu, Shaowei Qiu, Haiyan Xing, Runxia Gu, Junli Mou, Wanqing Xie, Zheng Tian, Kejing Tang, Qing Rao, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 3007–3008.

https://doi.org/10.1182/blood-2022-158859

Published: 2022

Journal Articles

The Investigation of Antitumor Effect of Humanized Bispecific BCMA/CD38 CAR-T Cells on Multiple Myeloma

Zhaoqi Chen, Yang Lu, Yingxi Xu, Shaowei Qiu, Runxia Gu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Dongsheng Xiong, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 7402–7403.

https://doi.org/10.1182/blood-2022-158133

Published: 2022

Journal Articles

Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells

Leling Xie, Runxia Gu, Xue Yang, Shaowei Qiu, Yingxi Xu, Junli Mou, Ying Wang, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 4535.

https://doi.org/10.1182/blood-2022-158682

Published: 2022

Journal Articles

Targeting Interferon Pathway in TBLR1-RARa-Driven Promyelocytic Leukemia in the Context of ATRA and ATO Unresponsiveness

Xue Yang, Haiyan Xing, Shaowei Qiu, Kejing Tang, Zheng Tian, Qing Rao, Min Wang, Jianxiang Wang

Blood (2022) 140 (Supplement 1): 11541.

https://doi.org/10.1182/blood-2022-157495

Published: 2022

Journal Articles

Role of AML1-ETO Related Fusion Circular RNA in the Growth of Leukemia Cells

Ying Wang, MD, Yingxi Xu, PhD, Qian Liu, Haiyan Xing, MS, Zheng Tian, BS, Kejing Tang, BS, Qing Rao, MS, Min Wang, MD, Jianxiang Wang, MD

Blood (2018) 132 (Supplement 1): 5130.

https://doi.org/10.1182/blood-2018-99-112728

Published: 2018

Journal Articles

The Impacts of Transcriptional Regulatory Mechanism and Protein Interaction Relationship between RUNX1 and KLF4 on the Biological Functions of t (8;21) Leukemia Cells

Shuang Liu, PhD, Wenting Lu, PhD, Shouyun Li, PhD, Saisai Li, PhD, Ying Wang, PhD, Jia Liu, MD, Zheng Tian, BS, Haiyan Xing, MS, Kejing Tang, BS, Yingxi Xu, PhD, Qing Rao, MS, Min Wang, MD, Jianxiang Wang, MD

Blood (2017) 130 (Supplement 1): 3802.

https://doi.org/10.1182/blood.V130.Suppl_1.3802.3802

Published: 2017

Journal Articles

Regulatory T Cells Promote the Stemness of Acute Myeloid Leukemia Cells through IL10 Cytokine Related Signaling Pathway

Yingxi Xu, PhD, Yuling Wan, PhD, Jia Liu, MD, Ying Wang, PhD, Saisai Li, PhD, Haiyan Xing, MS, Kejing Tang, BS, Zheng Tian, BS, Qing Rao, MS, Min Wang, MD, Jianxiang Wang, MD

Blood (2017) 130 (Supplement 1): 2727.

https://doi.org/10.1182/blood.V130.Suppl_1.2727.2727

Published: 2017

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The Chromatin Accessibility Landscape and Regulatory Network of CD34 Positive Cells in Acute Myeloid Leukemia

Integrative Multi-Omics Analyses Identify a High-Risk Subgroup of Patients with Poor Prognosis in t(8;21) Acute Myeloid Leukemia

ADGRG1/GPR56 As a Marker of CD8 + Tumor-Reactive T Cells in Acute Myeloid Leukemia

Mapping T-ALL to T Cell Differentiation Trajectory Identifies an ETP-like Subgroup Arrested at an Early Stage of T Cell Development

CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

The Immune Editing Process Reshapes the AML1-ETO Fusion Protein-Induced Pre-Leukemia Microenvironment

IKZF2 Specifically Participates in AML1-ETO Mediated Blockage of Myeloid Differentiation

Pre-Leukemic Transformation of the Bone Marrow Microenvironment Induced By AML1-ETO Fusion Protein

CRISPR-Cas9 Screening Identifies Therapeutic Targets for AML1-ETO Positive Leukemia

AML1-ETO and CCND2 Overexpression Cooperate to Drive AML Initiation and Progression

Structural Optimization of Dual-Target CD22/CD19 CAR-T and Its Anti-Tumor Effects on B Cell Malignancies

Construction of Dual- and Enhanced Dual-Antibodies Targeting CD19 in the Treatment of B-ALL and Investigation of the Relevant Mechanisms

The Characteristics of AML1-ETO Fusion Gene Induced Pre-Leukemia Immune Microenvironment

Investigation of Impact Induced By AML1-ETO on Self-Renewal and Differentiation of Hematopoietic Stem and Progenitor Cells in Pre-Leukemic Stage

The Investigation of Antitumor Effect of Humanized Bispecific BCMA/CD38 CAR-T Cells on Multiple Myeloma

Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells

Targeting Interferon Pathway in TBLR1-RARa-Driven Promyelocytic Leukemia in the Context of ATRA and ATO Unresponsiveness

Role of AML1-ETO Related Fusion Circular RNA in the Growth of Leukemia Cells

The Impacts of Transcriptional Regulatory Mechanism and Protein Interaction Relationship between RUNX1 and KLF4 on the Biological Functions of t (8;21) Leukemia Cells

Regulatory T Cells Promote the Stemness of Acute Myeloid Leukemia Cells through IL10 Cytokine Related Signaling Pathway

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only